|
 |
PlavixThis page contains recent news articles, when available, and an overview of Plavix but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Plavix (when available) Clopidogrel, an antiplatelet agent structurally and pharmacologically similar to ticlopidine, is used to reduce atherosclerotic events such as myocardial infarction, stroke, and vascular death in patients who have had a recent stroke, recent MI, or have established peripheral vascular disease. For the reduction of atherosclerotic events (myocardial infarction, stroke, and vascular death) in patients with atherosclerosis documented by recent stroke, recent myocardial infarction, or established peripheral arterial disease Mechanism Of Action: The active metabolite of Clopidogrel prevents binding of adenosine diphosphate (ADP) to its platelet receptor, impairing the ADP-mediated activation of the glycoprotein GPIIb/IIIa complex. It is proposed that the inhibition involves a defect in the mobilization from the storage sites of the platelet granules to the outer membrane. No direct interference occurs with the GPIIb/IIIa receptor. As the glycoprotein GPIIb/IIIa complex is the major receptor for fibrinogen, its impaired activation prevents fibrinogen binding to platelets and inhibits platelet aggregation. By blocking the amplification of platelet activation by released ADP, platelet aggregation induced by agonists other than ADP is also inhibited by the active metabolite of Clopidogrel. News Articles on Clopidogrel First-Ever National Ranking of 'Hot Spots' for Peripheral Artery ... - 16 Sep 2008 PLAVIX(R) (clopidogrel bisulfate) is the only prescription antiplatelet therapy with proven efficacy and a well-established safety profile for a broad range MarketWatch UPDATE 1-RESEARCH ALERT-JP Morgan cuts Eli Lilly to underweight - 16 Sep 2008 N: Quote, Profile, Research, Stock Buzz) $5 billion-a-year Plavix as the standard treatment to prevent heart attacks among heart patients, including those Reuters Open fractures can lead to bacterial infection called ... - 16 Sep 2008 6) Antiplatelet therapy: Aspirin (81-325mg/day), Plavix and Aggrenox are all recommended as initial treatment for preventing a recurrent stroke. Wilkes Barre Times-Leader, Study: Lilly's prasugrel beats Plavix - Sep 3, 2008 ...s experimental blood thinner prasugrel stopped clots more effectively than Plavix, a rival product made by Bristol- Myers Squibb Co. and Sanofi-Aventis SA, Indianapolis Star, Prasugrel seen better for diabetes patients than Plavix - Aug 31, 2008 T: Quote, Profile, Research, Stock Buzz) new blood-thinning drug prasugrel appears better for diabetes patients than Plavix, researchers said on Sunday. Reuters Fitch Affirms Bristol-Myers Squibb Co.'s IDR at 'A+'; Outlook Stable - Sep 12, 2008 The long-term debt schedule does not include significant maturities around the time of the Plavix patent expiration. Fitch's view includes Bristol-Myers MarketWatch Prasugrel better than Plavix for diabetics, says analysis - Sep 2, 2008 ...investigational oral antiplatelet drug prasugrel could be more beneficial for diabetics than Sanofi-Aventis/Bristol-Myers Squibb’s blockbuster Plavix. Pharma Times (subscription), Lilly releases study results for cardio drug - Aug 21, 2008 By TOM MURPHY 08.21.08, 11:56 AM ET The cardio drug prasugrel outperformed its competition, the blockbuster Plavix, in preventing recurring events like Forbes, Boehringer Drugs Disappoint in Company-Sponsored Stroke Study - Aug 27, 2008 The study also showed that Boehringer's blood thinner Aggrenox combined with aspirin was no better than a top-selling competitor, Plavix, in preventing Bloomberg Sanofi Ousts Chief Le Fur, Replaces With Viehbacher (Update3) - Sep 10, 2008 The drugmaker is seeking new products to replace revenue from its Plavix blood thinner, which faces patent expiration in 2011. Plavix had $4.76 billion in Bloomberg UPDATE: Suit Can Proceed Vs Bristol-Myers Over Disclosures - Aug 20, 2008 ...(BMY) over disclosures it made regarding its attempts to settle patent litigation with Canadian drug maker Apotex Inc. over popular blood thinner Plavix. CNNMoney.com Lilly, Daiichi’s Prasugrel Outperforms Plavix in Study - Aug 26, 2008 Patients were given a loading dose of prasugrel 60 mg or Plavix (clopidogrel) 300 mg, followed by a daily maintenance dose of either prasugrel 10 mg or FDA news (subscription), MIV Therapeutics VESTAsync™ Drug-Eluting Stent Trials Progress - Sep 15, 2008 Most importantly, patients in the VESTASYNC I study have not been taking anti-platelet medication (Plavix) for almost one year now and remain event free. Business Wire (press release), Immune System Implicated In - Aug 19, 2008 One set treated so that it lacked platelets altogether and two others were treated with aspirin or Plavix, platelet inhibitors that prevent the release of Oneindia, Study: Pfizer, Bristol-Myers drug boosts bleeding - Sep 2, 2008 The APPRAISE-1 study compared a combination of apixaban and standard treatments such as aspirin and Plavix to standard treatments alone. CNNMoney.com Income Investor - Sep 8, 2008 More recently, a court fight continues over Canadian company Apotex's 2006 launch of a generic competitor to Bristol-Myers' blood-thinning drug Plavix. Investor's Business Daily (subscription) Bristol-Myers Squibb Co. - From Hunted To Hunter.... - Aug 25, 2008 Due to exclusivity loss of cholesterol-lowering drug Pravachol and lower Plavix sales, Bristol-Myers' earnings in 2006 were lower than 2005. RTT News, CORRECT(8/31): Eli Lilly Prasugrel Risk Cut By 40%, Not 13.2% - Sep 3, 2008 By contrast, those who took Plavix, which Sanofi-Aventis co-markets with Bristol-Myers Squibb Co. (BMY) and had heart attacks were 13.2%, not reduced their EasyBourse.com, BMY Www.companiesandmarkets.com: Bristol-Myers Squibb Co ... - Sep 8, 2008 ...*Assess the level of generic exposure faced by Bristol-Myers Squibb out to 2013, driven primarily by patent expiry for its lead product Plavix in 2011. Trading Markets (press release), Feud May Brew Over Blood-Thinning Drugs - Aug 25, 2008 Co-marketed with France-based Sanofi-Avenits, Plavix generated $8.5 billion in sales last year. Defending Plavix's revenue and profits until its US patent RedOrbit, Statin might cause leg cramps; other factors likely, too - Aug 31, 2008 The only medications I take are a statin, niacin, Plavix and baby aspirin. Are any of them causing these aggravating cramps? A: It's possible. Denver Post, Seniors Tend to Bruise More Easily - Sep 5, 2008 So you might bruise more easily if you take Plavix or Coumadin. Aspirin will have a similar effect. The thinners allow more blood to pool under your skin. Consumer Affairs Pharmacy Offers Free Medication to Uninsured - Sep 4, 2008 Once an applicant is approved, it can take four to six weeks for the drugs to arrive, although the Med-Aid pharmacy keeps some popular drugs -- like Plavix, MyFox WGHP, Garden State Briefs - Sep 2, 2008 Apixaban could be a successor to Bristol-Myers' and partner Sa nofi-Aventis' blood thinner Plavix, which had $4.76 billion in 2007 sales, after the patent The Star-Ledger - NJ.com, Briefcase: August 23, 2008 - Aug 23, 2008 The cardio drug prasugrel outperformed its competition, the blockbuster Plavix, in preventing recurring events like heart attacks for some patients, South Bend Tribune, Korean Drugmakers at a Crossroads - Aug 27, 2008 Plavix generics were first released in January 2006, going on to take almost 50 percent of the blood-thinning drug market just 19 months later. 코리아타임즈, New drugs best stroke treatment - Aug 28, 2008 ...said the drugs which provided the extra protection were dipyridamole/aspirin, marketed as Asasantin, and clopidogrel, sold as Iscover or Plavix. The West Australian, Sitting Tight in September - Sep 4, 2008 In head-to-head testing versus Plavix, patients treated with prasugrel experienced a statistically significant reduction in serious cardiovascular disorders Motley Fool Sofley column: Mini-stroke as experienced by a speech pathologist - Aug 19, 2008 I am now on Plavix and pray daily that I will never have a full stroke. But I still have occasional symptoms, so I stay a bit scared. Salisbury Post, Study probes lower dose drugs for heart valve patients - Sep 11, 2008 ...and Plavix) alone," said investigator Marc Gerdisch, MD, CSA medical director and director of cardio-thoracic surgery at St. Francis Heart Center. Indianapolis Star, Sanofi names Viehbacher as new CEO - Sep 10, 2008 ...when Swiss drug maker Schweizerhall said it expected to receive approval to sell a generic version of Sanofi-Aventis' anti-clotting agent Plavix. The Associated Press Germany Pharmaceuticals and Healthcare Report Q3 2008 - www ... - Sep 12, 2008 Several cases of drugs being declined for reimbursement have arisen during early 2008, including Plavix (clopidogrel), Viagra (sildenafil), PR-Inside.com (Pressemitteilung), A lack of chemistry - Sep 4, 2008 Last year, UAE custom officials seized a number of counterfeit caches in free zones, including a haul of fake clopidogrel (Plavix) worth $1.36 million. ArabianBusiness.com, New Drug Protects Against Second Heart Attack or Stroke, Study ... - Sep 2, 2008 Most are prescribed aspirin, clopidogrel (also known as Plavix or Iscover) and/or warfarin. "Warfarin is clearly effective as an anticoagulant, Science Daily (press release) A Big Upgrade for Eli Lilly - Aug 28, 2008 Investors also anxiously await blood-thinner Prasugrel’s FDA approval in September, which is expected to compete with Plavix, sold by Bristol-Myers Squibb Motley Fool Targanta Therapeutics Announces Appointment of Two New Board Members - Aug 26, 2008 Under her leadership, BMS launched several blockbuster therapeutic drugs including Plavix(R) for the prevention of blood clots. Ms. Crane is a graduate of MarketWatch Health & Medicine - Sep 5, 2008 Its big money-maker, the $4 billion-a-year anticoagulant Plavix, loses patent protection in 2011. Anticipating the loss of income, Bristol announced late Investor's Business Daily (subscription) Lilly's Brewing Battle With Bristol And Your Emails - Sep 5, 2008 Effient would compete with Bristol-Myers Squibb's top-selling drug in that category, Plavix. Blogreader Dewey Steadman, an Equity Research Associate on the CNBC, New laboratory sees Sanofi take the fight to counterfeiters - Sep 5, 2008 ...as conducting tests on suspect samples of commonly counterfeited Sanofi products, notably the company’s blockbuster bloodthinner Plavix (clopidogrel). Pharma Times (subscription), Multinationals seriously overcharge for some drugs - Sep 4, 2008 Clopidogrel, the popular heart drug branded Plavix by Sanofi is priced at Rs 1530 for ten tablets. That’s nearly 20 times costlier than what a strip of Daily News & Analysis, ESC: Experimental Anticoagulant Shows Promise in Phase II Study - Sep 4, 2008 About 25% of patients were taking aspirin alone; 75% were on dual antiplatelet therapy -- aspirin and clopidogrel (Plavix). Patients were randomly assigned MedPage Today, Judge allows shareholder suit over Plavix disclosures - Aug 21, 2008 The drugmaker said its efforts to settle the Plavix case with Apotex, a Canadian generic-drug maker, "were at all times full, fair and accurate. SmartBrief, Judge allows shareholder suit over Plavix disclosures - Aug 21, 2008 The drugmaker said its efforts to settle the Plavix case with Apotex, a Canadian generic-drug maker, "were at all times full, fair and accurate. SmartBrief, PROFESS: No neuroprotective effect of dipyridamole, aspirin, or ... - Sep 3, 2008 25 mg plus extended-release dipyridamole 200 mg twice daily or clopidogrel 75 mg (Plavix/Iscover, Bristol-Myers Squibb/ Sanofi-Aventis) once daily. TheHeart.Org, Boehringer Ingelheim Drugs Have No Stroke Advantage - Sep 2, 2008 The other study found that Aggrenox (aspirin/dipyridamole) worked no better than Sanofi-Aventis and Bristol-Myers Squibb’s Plavix (clopidogrel bisulfate) in FDA news (subscription), Fish oil beats Crestor for heart failure - Sep 2, 2008 Eli Lilly and Daiichi Sankyo's new blood thinner prasugrel appears to work better in diabetic patients than the common anti-clotting med Plavix does, FiercePharma, Daily Briefs: Electoral Dice-Rolling - Sep 2, 2008 Bristol, who was named for beloved pharmaceutical giant Bristol-Myers Squibb (NYSE: BMY), manufacturer of Plavix® oral antiplatelet agent. Pitch Weekly, TRITON-TIMI 38 analysis of diabetics finds clinical gains but no ... - Sep 1, 2008 Munich, Germany - If an increased bleeding risk is the price of using prasugrel (Eli Lilly/Daiichi Sankyo) instead of clopidogrel (Plavix/Iscover, TheHeart.Org, Help is available on Medicare D coverage gap - Aug 31, 2008 The most medicines most commonly ordered for those in the coverage gap are Plavix, Lipitor, Crestor, Advair Discus, Nexium and Protonix, according to Martinsville Bulletin, PROFESS trial published: Combination therapy falls short of ... - Aug 28, 2008 Boehringer Ingelheim) did not meet prespecified criteria for noninferiority vs clopidogrel (Plavix/Iscover, Sanofi-Aventis/Bristol-Myers Squibb), TheHeart.Org, Brand Names/Synonyms: Plavix is also known by the following brand names and/or synonymsCLOPIDOGREL SULFATE; Clopidogrel; Clopidogrel [Ban:Inn]; Plavix Drug Category: Plavix is categorized under the following by the FDA: Antiplatelet Agents; Platelet Aggregation Inhibitors; Fibrinolytic Agents; ATC:B01AC04 Dosage Forms: round, biconvex, film- coated tablet Absorption: at least 50% Interactions: Aspirin, warfarin, heparin, NSAIDs Chemical IUPAC Name: methyl2-(2-chlorophenyl)-2-(7-thia-3-azabicyclo[4.3.0]nona-8,10-dien-3-yl)ethanoate : |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines mongabay.com
COPYRIGHT 2007 MONGABAY.COM |